EP2289879
Synthesis of a crystalline form of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide tartrate salt
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
26.9.2005EP published:
12.11.2014EP application number:
10180395.5
EPO information:
European Patent Register
Max expiry date:
25.9.2025
Title:
Synthesis of a crystalline form of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide tartrate salt
Timeline
Today
26.9.2005EP application
12.11.2014EP Publication
Owner
Name:
Acadia Pharmaceuticals Inc.Address:
11085 Torreyana Road, Ste. 100, 92121-1104, San-Diego, CA, US
Inventor
Name:
Thygesen, MikkelAddress:
Copenhagen, DK
Name:
Schlienger, NathalieAddress:
Zürich, CH
Name:
Tolf, Bo-RagnarAddress:
Trosa, SE
Name:
Andersson, Carl-MagnusAddress:
245 64, Hjärup, SE
Name:
Blatter, FritzAddress:
Reinach, CH
Name:
Berghausen, JörgAddress:
Lörrach, DE
Priority
Number:
614014 PDate:
27.9.2004Country:
US
Classification
Categories:
C07D 211/58, A61K 31/4468, A61P 25/00, A61P 7/02